Abstract: The present invention relates to a device for identifying anomalies on medical instruments, having a data processing installation and an instrument analyzing unit. The data processing installation has a display unit, a database, a first interface and an evaluation unit and the instrument analyzing unit has a support and at least one camera. The at least one camera is arranged and oriented such that it can capture image data from medical instruments arranged on the support from at least one perspective, and the data processing installation is designed such that it uses the first interface to receive image data from the at least one camera and can store the received image data in the database. Further, it can use the evaluation unit to examine said image data for regions which have anomalies. In addition, the invention also relates to an according method.

Abstract: A method is disclosed for segmenting an organ from volume data sets in medical imaging. A likelihood data set is generated. A binary data set is generated with the aid of a threshold value method, in which the organ region is eroded step by step. When the organ region is separated into a number of subregions, only one of the subregions, which is most likely to contain the organ, is selected for further erosion in each instance. This subregion is identified from geometrical features of the organ, which are known from the training data sets. In the likelihood data set the likelihood values of voxels of the subregions separated in the binary data set are reduced, so that a correspondingly corrected likelihood data set results. On the basis of this corrected likelihood data set the organ from the likelihood data set is segmented.

Abstract: A method is disclosed for segmenting an organ, more particularly the liver, in n-channel volume data records from magnetic resonance imaging. In at least one embodiment of the method, probability distributions are generated on the basis of segmentation results from n-channel training data records, which probability distributions specify probabilities of positions of voxels and intensity values, which have been reduced from n-dimensions to one dimension with the aid of discriminant reduction, of voxels in the training data records belonging to the organ. At least one 3D probability data record is then generated from the n-channel volume data records on the basis of the probability distributions, in which 3D probability data record each voxel is assigned a probability of belonging to the organ. A maximum value of the 3D probability data record is set as the start point for the segmentation, and the organ is subsequently segmented on the basis of the 3D probability data record using a region-growing technique.

Abstract: The invention relates to a device for assembling sets of instruments, having a data processing installation and a fine identification unit. The data processing installation has a display unit, a database, a first interface and an evaluation unit. The fine identification unit has a first support for placing the instruments of a set of instruments thereon and a first camera. The first camera is arranged and oriented such that it can capture image data from instruments to be identified and arranged on the first support from at least one perspective, and the data processing installation is designed such that it uses the first interface to receive image data from the first camera and can store the received image data in the database. It can further visually identify a respective instrument by use of the evaluation unit. The invention also relates to an according method for assembling sets of instruments.

Abstract: The present invention relates to a device for identifying anomalies on medical instruments, having a data processing installation and an instrument analysing unit. The data processing installation has a display unit, a database, a first interface and an evaluation unit and the instrument analysing unit has a support and at least one camera. The at least one camera is arranged and oriented such that it can capture image data from medical instruments arranged on the support from at least one perspective, and the data processing installation is designed such that it uses the first interface to receive image data from the at least one camera and can store the received image data in the database. Further, it can use the evaluation unit to examine said image data for regions which have anomalies. In addition, the invention also relates to an according method.

Abstract: The invention relates to a method for the production of a medicament containing a polypeptide comprising at least one recombinant carbohydrate-binding polypeptide, or a functional fragment or derivative of said carbohydrate-binding polypeptide in a form stable for storage. The polypeptide mentioned comprises polypeptides or functional derivatives thereof, which are fused with cytotoxically effective peptides to give fusion proteins, or which are linked to another polypeptide having a cytotoxic activity. Moreover, the invention describes further formulating of the disclosed medicaments to medicaments with different pharmaceutical forms.

Abstract: The invention relates to a device for identifying instruments comprising at least one weight sensor, a data processing system, which has an interface, at least one database and an processing unit, and a visualization unit. Weight distribution data of instruments can be determined and compared by the device. This allows identifying individual instruments. The invention further relates to according methods for detecting a weight distribution of an individual instrument and for identifying an individual instrument, as well as to a method for assembling instrument sets.

Abstract: A method is disclosed for segmenting an organ from volume data sets in medical imaging. A likelihood data set is generated. A binary data set is generated with the aid of a threshold value method, in which the organ region is eroded step by step. When the organ region is separated into a number of subregions, only one of the subregions, which is most likely to contain the organ, is selected for further erosion in each instance. This subregion is identified from geometrical features of the organ, which are known from the training data sets. In the likelihood data set the likelihood values of voxels of the subregions separated in the binary data set are reduced, so that a correspondingly corrected likelihood data set results. On the basis of this corrected likelihood data set the organ from the likelihood data set is segmented.

Abstract: The invention relates to a method for contraception comprising the administration of trimegestone to a woman of child-bearing age on at least 21 successive days, beginning on day 1 of the menstrual cycle, wherein on at least one of the at least 21 successive days the daily dose of trimegestone is more than 500 ?g.

Abstract: The invention relates to a method for the production of a medicament containing a polypeptide comprising at least one recombinant carbohydrate-binding polypeptide, or a functional fragment or derivative of said carbohydrate-binding polypeptide in a form stable for storage. The polypeptide mentioned comprises polypeptides or functional derivatives thereof, which are fused with cytotoxically effective peptides to give fusion proteins, or which are linked to another polypeptide having a cytotoxic activity. Moreover, the invention describes further formulating of the disclosed medicaments to medicaments with different pharmaceutical forms.

Abstract: A method is disclosed for segmenting an organ, more particularly the liver, in n-channel volume data records from magnetic resonance imaging. In at least one embodiment of the method, probability distributions are generated on the basis of segmentation results from n-channel training data records, which probability distributions specify probabilities of positions of voxels and intensity values, which have been reduced from n-dimensions to one dimension with the aid of discriminant reduction, of voxels in the training data records belonging to the organ. At least one 3D probability data record is then generated from the n-channel volume data records on the basis of the probability distributions, in which 3D probability data record each voxel is assigned a probability of belonging to the organ. A maximum value of the 3D probability data record is set as the start point for the segmentation, and the organ is subsequently segmented on the basis of the 3D probability data record using a region-growing technique.

Abstract: The invention relates to a method for contraception comprising the administration of trimegestone to a woman of child-bearing age on at least 21 successive days, beginning on day 1 of the menstrual cycle, wherein on at least one of the at least 21 successive days the daily dose of trimegestone is more than 500 ?g.

Abstract: The invention relates to a method for the production of a medicament containing a polypeptide comprising at least one recombinant carbohydrate-binding polypeptide, or a functional fragment or derivative of said carbohydrate-binding polypeptide in a form stable for storage. The polypeptide mentioned comprises polypeptides or functional derivatives thereof, which are fused with cytotoxically effective peptides to give fusion proteins, or which are linked to another polypeptide having a cytotoxic activity. Moreover, the invention describes further formulating of the disclosed medicaments to medicaments with different pharmaceutical forms.

Abstract: The invention relates to a method for contraception comprising the administration of trimegestone to a woman of child-bearing age on at least 21 successive days, beginning on day 1 of the menstrual cycle, wherein on at least one of the at least 21 successive days the daily dose of trimegestone is more than 500 ?g.

Abstract: The invention relates to a method for the production of a medicament containing a polypeptide comprising at least one recombinant carbohydrate-binding polypeptide, or a functional fragment or derivative of said carbohydrate-binding polypeptide in a form stable for storage. The polypeptide mentioned comprises polypeptides or functional derivatives thereof, which are fused with cytotoxically effective peptides to give fusion proteins, or which are linked to another polypeptide having a cytotoxic activity. Moreover, the invention describes further formulating of the disclosed medicaments to medicaments with different pharmaceutical forms.